id	sid	tid	token	lemma	pos
dpc-5695	1	1	dermatology	dermatology	NOUN
dpc-5695	1	2	:	:	PUNCT
dpc-5695	1	3	practical	practical	ADJ
dpc-5695	1	4	and	and	CCONJ
dpc-5695	1	5	conceptual	conceptual	ADJ
dpc-5695	1	6	research	research	NOUN
dpc-5695	1	7	letter	letter	NOUN
dpc-5695	2	1	|	|	ADV
dpc-5695	2	2	dermatol	dermatol	ADJ
dpc-5695	2	3	pract	pract	NOUN
dpc-5695	2	4	concept	concept	NOUN
dpc-5695	2	5	.	.	PUNCT
dpc-5695	3	1	2025;15(4):5695	2025;15(4):5695	NUM
dpc-5695	3	2	1	1	NUM
dpc-5695	3	3	betamethasone	betamethasone	NOUN
dpc-5695	3	4	-	-	PUNCT
dpc-5695	3	5	calcipotriol	calcipotriol	NOUN
dpc-5695	3	6	foam	foam	NOUN
dpc-5695	3	7	:	:	PUNCT
dpc-5695	3	8	a	a	DET
dpc-5695	3	9	promising	promising	ADJ
dpc-5695	3	10	treatment	treatment	NOUN
dpc-5695	3	11	for	for	ADP
dpc-5695	3	12	erythema	erythema	ADJ
dpc-5695	3	13	annulare	annulare	NOUN
dpc-5695	3	14	centrifugum	centrifugum	NOUN
dpc-5695	3	15	with	with	ADP
dpc-5695	3	16	lc	lc	NOUN
dpc-5695	3	17	-	-	PUNCT
dpc-5695	3	18	oct	oct	PROPN
dpc-5695	3	19	monitoring	monitoring	PROPN
dpc-5695	3	20	caterina	caterina	PROPN
dpc-5695	3	21	mariarosaria	mariarosaria	PROPN
dpc-5695	3	22	giorgio1	giorgio1	PROPN
dpc-5695	3	23	,	,	PUNCT
dpc-5695	3	24	gaetano	gaetano	PROPN
dpc-5695	3	25	licata2	licata2	PROPN
dpc-5695	3	26	,	,	PUNCT
dpc-5695	3	27	eugenia	eugenia	PROPN
dpc-5695	3	28	veronica	veronica	PROPN
dpc-5695	3	29	di	di	PROPN
dpc-5695	3	30	brizzi1	brizzi1	PROPN
dpc-5695	3	31	,	,	PUNCT
dpc-5695	3	32	elvira	elvira	PROPN
dpc-5695	3	33	moscarella1	moscarella1	PROPN
dpc-5695	3	34	,	,	PUNCT
dpc-5695	3	35	giuseppe	giuseppe	PROPN
dpc-5695	3	36	argenziano1	argenziano1	PROPN
dpc-5695	3	37	,	,	PUNCT
dpc-5695	3	38	vittorio	vittorio	PROPN
dpc-5695	3	39	tancredi1	tancredi1	NOUN
dpc-5695	3	40	1	1	NUM
dpc-5695	3	41	dermatology	dermatology	NOUN
dpc-5695	3	42	unit	unit	NOUN
dpc-5695	3	43	,	,	PUNCT
dpc-5695	3	44	department	department	NOUN
dpc-5695	3	45	of	of	ADP
dpc-5695	3	46	mental	mental	ADJ
dpc-5695	3	47	and	and	CCONJ
dpc-5695	3	48	physical	physical	ADJ
dpc-5695	3	49	health	health	NOUN
dpc-5695	3	50	and	and	CCONJ
dpc-5695	3	51	preventive	preventive	ADJ
dpc-5695	3	52	medicine	medicine	NOUN
dpc-5695	3	53	,	,	PUNCT
dpc-5695	3	54	university	university	PROPN
dpc-5695	3	55	of	of	ADP
dpc-5695	3	56	campania	campania	PROPN
dpc-5695	3	57	luigi	luigi	PROPN
dpc-5695	3	58	vanvitelli	vanvitelli	PROPN
dpc-5695	3	59	,	,	PUNCT
dpc-5695	3	60	naples	naples	PROPN
dpc-5695	3	61	,	,	PUNCT
dpc-5695	3	62	italy	italy	PROPN
dpc-5695	3	63	2	2	NUM
dpc-5695	3	64	dermatology	dermatology	NOUN
dpc-5695	3	65	unit	unit	NOUN
dpc-5695	3	66	,	,	PUNCT
dpc-5695	3	67	san	san	PROPN
dpc-5695	3	68	antonio	antonio	PROPN
dpc-5695	3	69	abate	abate	VERB
dpc-5695	3	70	hospital	hospital	NOUN
dpc-5695	3	71	,	,	PUNCT
dpc-5695	3	72	trapani	trapani	X
dpc-5695	3	73	,	,	PUNCT
dpc-5695	3	74	italy	italy	PROPN
dpc-5695	3	75	key	key	ADJ
dpc-5695	3	76	words	word	NOUN
dpc-5695	3	77	:	:	PUNCT
dpc-5695	3	78	betamethasone	betamethasone	NOUN
dpc-5695	3	79	-	-	PUNCT
dpc-5695	3	80	calcipotriol	calcipotriol	PROPN
dpc-5695	3	81	,	,	PUNCT
dpc-5695	3	82	erythema	erythema	ADJ
dpc-5695	3	83	annulare	annulare	NOUN
dpc-5695	3	84	centrifugum	centrifugum	NOUN
dpc-5695	3	85	,	,	PUNCT
dpc-5695	3	86	lc	lc	PROPN
dpc-5695	3	87	-	-	PUNCT
dpc-5695	3	88	oct	oct	NOUN
dpc-5695	3	89	citation	citation	NOUN
dpc-5695	3	90	:	:	PUNCT
dpc-5695	3	91	giorgio	giorgio	PROPN
dpc-5695	3	92	cm	cm	PROPN
dpc-5695	3	93	,	,	PUNCT
dpc-5695	3	94	licata	licata	VERB
dpc-5695	3	95	g	g	NOUN
dpc-5695	3	96	,	,	PUNCT
dpc-5695	3	97	di	di	PROPN
dpc-5695	3	98	brizzi	brizzi	PROPN
dpc-5695	3	99	ev	ev	PROPN
dpc-5695	3	100	,	,	PUNCT
dpc-5695	3	101	moscarella	moscarella	NOUN
dpc-5695	3	102	e	e	NOUN
dpc-5695	3	103	,	,	PUNCT
dpc-5695	3	104	argenziano	argenziano	ADJ
dpc-5695	3	105	g	g	NOUN
dpc-5695	3	106	,	,	PUNCT
dpc-5695	3	107	tancredi	tancredi	NOUN
dpc-5695	3	108	v.	v.	ADP
dpc-5695	3	109	betamethasone	betamethasone	PROPN
dpc-5695	3	110	-	-	PUNCT
dpc-5695	3	111	calcipotriol	calcipotriol	PROPN
dpc-5695	3	112	foam	foam	NOUN
dpc-5695	3	113	:	:	PUNCT
dpc-5695	3	114	a	a	DET
dpc-5695	3	115	promising	promising	ADJ
dpc-5695	3	116	treatment	treatment	NOUN
dpc-5695	3	117	for	for	ADP
dpc-5695	3	118	erythema	erythema	ADJ
dpc-5695	3	119	annulare	annulare	NOUN
dpc-5695	3	120	centrifugum	centrifugum	NOUN
dpc-5695	3	121	with	with	ADP
dpc-5695	3	122	lc	lc	NOUN
dpc-5695	3	123	-	-	PUNCT
dpc-5695	3	124	oct	oct	NOUN
dpc-5695	3	125	monitoring	monitoring	NOUN
dpc-5695	3	126	.	.	PUNCT
dpc-5695	4	1	dermatol	dermatol	NOUN
dpc-5695	4	2	pract	pract	PROPN
dpc-5695	4	3	concept	concept	NOUN
dpc-5695	4	4	.	.	PUNCT
dpc-5695	5	1	2025;15(4):5695	2025;15(4):5695	X
dpc-5695	5	2	.	.	PUNCT
dpc-5695	6	1	doi	doi	NOUN
dpc-5695	6	2	:	:	PUNCT
dpc-5695	6	3	https://doi	https://doi	PROPN
dpc-5695	6	4	.	.	PUNCT
dpc-5695	6	5	org/10.5826	org/10.5826	NUM
dpc-5695	6	6	/	/	SYM
dpc-5695	6	7	dpc.1504a5695	dpc.1504a5695	NOUN
dpc-5695	6	8	accepted	accept	VERB
dpc-5695	6	9	:	:	PUNCT
dpc-5695	6	10	april	april	PROPN
dpc-5695	6	11	15	15	NUM
dpc-5695	6	12	,	,	PUNCT
dpc-5695	6	13	2025	2025	NUM
dpc-5695	6	14	;	;	PUNCT
dpc-5695	6	15	published	publish	VERB
dpc-5695	6	16	:	:	PUNCT
dpc-5695	7	1	october	october	PROPN
dpc-5695	7	2	2025	2025	NUM
dpc-5695	7	3	copyright	copyright	NOUN
dpc-5695	7	4	:	:	PUNCT
dpc-5695	7	5	©	©	PROPN
dpc-5695	7	6	2025	2025	NUM
dpc-5695	7	7	giorgio	giorgio	PROPN
dpc-5695	7	8	et	et	PROPN
dpc-5695	7	9	al	al	PROPN
dpc-5695	7	10	.	.	PUNCT
dpc-5695	8	1	this	this	PRON
dpc-5695	8	2	is	be	AUX
dpc-5695	8	3	an	an	DET
dpc-5695	8	4	open	open	ADJ
dpc-5695	8	5	-	-	PUNCT
dpc-5695	8	6	access	access	NOUN
dpc-5695	8	7	article	article	NOUN
dpc-5695	8	8	distributed	distribute	VERB
dpc-5695	8	9	under	under	ADP
dpc-5695	8	10	the	the	DET
dpc-5695	8	11	terms	term	NOUN
dpc-5695	8	12	of	of	ADP
dpc-5695	8	13	the	the	DET
dpc-5695	8	14	creative	creative	ADJ
dpc-5695	8	15	commons	common	NOUN
dpc-5695	8	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-5695	8	17	license	license	NOUN
dpc-5695	8	18	(	(	PUNCT
dpc-5695	8	19	by	by	ADP
dpc-5695	8	20	-	-	PUNCT
dpc-5695	8	21	nc-4.0	nc-4.0	NOUN
dpc-5695	8	22	)	)	PUNCT
dpc-5695	8	23	,	,	PUNCT
dpc-5695	8	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-5695	8	25	,	,	PUNCT
dpc-5695	8	26	which	which	PRON
dpc-5695	8	27	permits	permit	VERB
dpc-5695	8	28	unrestricted	unrestricted	ADJ
dpc-5695	8	29	noncommercial	noncommercial	ADJ
dpc-5695	8	30	use	use	NOUN
dpc-5695	8	31	,	,	PUNCT
dpc-5695	8	32	distribution	distribution	NOUN
dpc-5695	8	33	,	,	PUNCT
dpc-5695	8	34	and	and	CCONJ
dpc-5695	8	35	reproduction	reproduction	NOUN
dpc-5695	8	36	in	in	ADP
dpc-5695	8	37	any	any	DET
dpc-5695	8	38	medium	medium	NOUN
dpc-5695	8	39	,	,	PUNCT
dpc-5695	8	40	provided	provide	VERB
dpc-5695	8	41	the	the	DET
dpc-5695	8	42	original	original	ADJ
dpc-5695	8	43	authors	author	NOUN
dpc-5695	8	44	and	and	CCONJ
dpc-5695	8	45	source	source	NOUN
dpc-5695	8	46	are	be	AUX
dpc-5695	8	47	credited	credit	VERB
dpc-5695	8	48	.	.	PUNCT
dpc-5695	9	1	funding	funding	NOUN
dpc-5695	9	2	:	:	PUNCT
dpc-5695	9	3	none	none	NOUN
dpc-5695	9	4	.	.	PUNCT
dpc-5695	10	1	competing	compete	VERB
dpc-5695	10	2	interests	interest	NOUN
dpc-5695	10	3	:	:	PUNCT
dpc-5695	10	4	none	none	NOUN
dpc-5695	10	5	.	.	PUNCT
dpc-5695	11	1	authorship	authorship	NOUN
dpc-5695	11	2	:	:	PUNCT
dpc-5695	11	3	all	all	DET
dpc-5695	11	4	authors	author	NOUN
dpc-5695	11	5	have	have	AUX
dpc-5695	11	6	contributed	contribute	VERB
dpc-5695	11	7	significantly	significantly	ADV
dpc-5695	11	8	to	to	ADP
dpc-5695	11	9	this	this	DET
dpc-5695	11	10	publication	publication	NOUN
dpc-5695	11	11	.	.	PUNCT
dpc-5695	12	1	corresponding	correspond	VERB
dpc-5695	12	2	author	author	NOUN
dpc-5695	12	3	:	:	PUNCT
dpc-5695	12	4	vittorio	vittorio	PROPN
dpc-5695	12	5	tancredi	tancredi	PROPN
dpc-5695	12	6	,	,	PUNCT
dpc-5695	12	7	md	md	PROPN
dpc-5695	12	8	,	,	PUNCT
dpc-5695	12	9	dermatology	dermatology	NOUN
dpc-5695	12	10	unit	unit	NOUN
dpc-5695	12	11	,	,	PUNCT
dpc-5695	12	12	department	department	NOUN
dpc-5695	12	13	of	of	ADP
dpc-5695	12	14	mental	mental	ADJ
dpc-5695	12	15	and	and	CCONJ
dpc-5695	12	16	physical	physical	ADJ
dpc-5695	12	17	health	health	NOUN
dpc-5695	12	18	and	and	CCONJ
dpc-5695	12	19	preventive	preventive	ADJ
dpc-5695	12	20	medicine	medicine	NOUN
dpc-5695	12	21	,	,	PUNCT
dpc-5695	12	22	university	university	PROPN
dpc-5695	12	23	of	of	ADP
dpc-5695	12	24	campania	campania	PROPN
dpc-5695	12	25	luigi	luigi	PROPN
dpc-5695	12	26	vanvitelli	vanvitelli	PROPN
dpc-5695	12	27	,	,	PUNCT
dpc-5695	12	28	naples	naples	PROPN
dpc-5695	12	29	,	,	PUNCT
dpc-5695	12	30	italy	italy	PROPN
dpc-5695	12	31	.	.	PUNCT
dpc-5695	13	1	orcid	orcid	PROPN
dpc-5695	14	1	i	i	PRON
dpc-5695	14	2	d	d	PROPN
dpc-5695	14	3	:	:	PUNCT
dpc-5695	14	4	r:0009	r:0009	NOUN
dpc-5695	14	5	-	-	PUNCT
dpc-5695	14	6	0009	0009	NUM
dpc-5695	14	7	-	-	PUNCT
dpc-5695	14	8	4276	4276	NUM
dpc-5695	14	9	-	-	PUNCT
dpc-5695	14	10	0028	0028	NUM
dpc-5695	14	11	.	.	PUNCT
dpc-5695	15	1	e	e	X
dpc-5695	15	2	-	-	NOUN
dpc-5695	15	3	mail	mail	NOUN
dpc-5695	15	4	:	:	PUNCT
dpc-5695	16	1	tancredivittorio@ymail.com	tancredivittorio@ymail.com	X
dpc-5695	16	2	introduction	introduction	NOUN
dpc-5695	16	3	erythema	erythema	ADJ
dpc-5695	16	4	annulare	annulare	NOUN
dpc-5695	16	5	centrifugum	centrifugum	NOUN
dpc-5695	16	6	(	(	PUNCT
dpc-5695	16	7	eac	eac	PROPN
dpc-5695	16	8	)	)	PUNCT
dpc-5695	16	9	is	be	AUX
dpc-5695	16	10	a	a	DET
dpc-5695	16	11	rare	rare	ADJ
dpc-5695	16	12	inflammatory	inflammatory	ADJ
dpc-5695	16	13	skin	skin	NOUN
dpc-5695	16	14	disorder	disorder	NOUN
dpc-5695	16	15	characterized	characterize	VERB
dpc-5695	16	16	by	by	ADP
dpc-5695	16	17	annular	annular	ADJ
dpc-5695	16	18	erythematous	erythematous	ADJ
dpc-5695	16	19	lesions	lesion	NOUN
dpc-5695	16	20	that	that	PRON
dpc-5695	16	21	expand	expand	VERB
dpc-5695	16	22	centrifugally	centrifugally	ADV
dpc-5695	16	23	with	with	ADP
dpc-5695	16	24	central	central	ADJ
dpc-5695	16	25	clearing	clearing	NOUN
dpc-5695	16	26	.	.	PUNCT
dpc-5695	17	1	effective	effective	ADJ
dpc-5695	17	2	treatment	treatment	NOUN
dpc-5695	17	3	is	be	AUX
dpc-5695	17	4	challenging	challenging	ADJ
dpc-5695	17	5	,	,	PUNCT
dpc-5695	17	6	particularly	particularly	ADV
dpc-5695	17	7	when	when	SCONJ
dpc-5695	17	8	the	the	DET
dpc-5695	17	9	cause	cause	NOUN
dpc-5695	17	10	is	be	AUX
dpc-5695	17	11	idiopathic	idiopathic	ADJ
dpc-5695	17	12	or	or	CCONJ
dpc-5695	17	13	resistant	resistant	ADJ
dpc-5695	17	14	to	to	ADP
dpc-5695	17	15	conventional	conventional	ADJ
dpc-5695	17	16	therapies	therapy	NOUN
dpc-5695	17	17	[	[	X
dpc-5695	17	18	1	1	NUM
dpc-5695	17	19	]	]	PUNCT
dpc-5695	17	20	.	.	PUNCT
dpc-5695	18	1	in	in	ADP
dpc-5695	18	2	this	this	DET
dpc-5695	18	3	case	case	NOUN
dpc-5695	18	4	series	series	NOUN
dpc-5695	18	5	,	,	PUNCT
dpc-5695	18	6	we	we	PRON
dpc-5695	18	7	explored	explore	VERB
dpc-5695	18	8	the	the	DET
dpc-5695	18	9	use	use	NOUN
dpc-5695	18	10	of	of	ADP
dpc-5695	18	11	calcipotriol	calcipotriol	NOUN
dpc-5695	18	12	-	-	PUNCT
dpc-5695	18	13	betamethasone	betamethasone	PROPN
dpc-5695	18	14	foam	foam	NOUN
dpc-5695	18	15	in	in	ADP
dpc-5695	18	16	five	five	NUM
dpc-5695	18	17	patients	patient	NOUN
dpc-5695	18	18	with	with	ADP
dpc-5695	18	19	clinically	clinically	ADV
dpc-5695	18	20	and	and	CCONJ
dpc-5695	18	21	histologically	histologically	ADV
dpc-5695	18	22	confirmed	confirm	VERB
dpc-5695	18	23	eac	eac	PROPN
dpc-5695	18	24	,	,	PUNCT
dpc-5695	18	25	employing	employ	VERB
dpc-5695	18	26	line	line	NOUN
dpc-5695	18	27	-	-	PUNCT
dpc-5695	18	28	field	field	NOUN
dpc-5695	18	29	confocal	confocal	ADJ
dpc-5695	18	30	optical	optical	ADJ
dpc-5695	18	31	coherence	coherence	NOUN
dpc-5695	18	32	tomography	tomography	NOUN
dpc-5695	18	33	(	(	PUNCT
dpc-5695	18	34	lc	lc	PROPN
dpc-5695	18	35	-	-	PUNCT
dpc-5695	18	36	oct	oct	NOUN
dpc-5695	18	37	)	)	PUNCT
dpc-5695	18	38	to	to	PART
dpc-5695	18	39	monitor	monitor	VERB
dpc-5695	18	40	treatment	treatment	NOUN
dpc-5695	18	41	response	response	NOUN
dpc-5695	18	42	.	.	PUNCT
dpc-5695	19	1	while	while	SCONJ
dpc-5695	19	2	corticosteroids	corticosteroid	NOUN
dpc-5695	19	3	are	be	AUX
dpc-5695	19	4	the	the	DET
dpc-5695	19	5	standard	standard	NOUN
dpc-5695	19	6	of	of	ADP
dpc-5695	19	7	care	care	NOUN
dpc-5695	19	8	for	for	ADP
dpc-5695	19	9	eac	eac	PROPN
dpc-5695	19	10	,	,	PUNCT
dpc-5695	19	11	prolonged	prolong	VERB
dpc-5695	19	12	use	use	NOUN
dpc-5695	19	13	risks	risk	NOUN
dpc-5695	19	14	side	side	NOUN
dpc-5695	19	15	effects	effect	NOUN
dpc-5695	19	16	such	such	ADJ
dpc-5695	19	17	as	as	ADP
dpc-5695	19	18	skin	skin	NOUN
dpc-5695	19	19	atrophy	atrophy	NOUN
dpc-5695	19	20	.	.	PUNCT
dpc-5695	20	1	the	the	DET
dpc-5695	20	2	combination	combination	NOUN
dpc-5695	20	3	of	of	ADP
dpc-5695	20	4	calcipotriol	calcipotriol	PROPN
dpc-5695	20	5	and	and	CCONJ
dpc-5695	20	6	betamethasone	betamethasone	NOUN
dpc-5695	20	7	addresses	address	VERB
dpc-5695	20	8	these	these	DET
dpc-5695	20	9	concerns	concern	NOUN
dpc-5695	20	10	by	by	ADP
dpc-5695	20	11	combining	combine	VERB
dpc-5695	20	12	anti	anti	ADJ
dpc-5695	20	13	-	-	ADJ
dpc-5695	20	14	inflammatory	inflammatory	ADJ
dpc-5695	20	15	and	and	CCONJ
dpc-5695	20	16	antiproliferative	antiproliferative	ADJ
dpc-5695	20	17	effects	effect	NOUN
dpc-5695	20	18	,	,	PUNCT
dpc-5695	20	19	with	with	ADP
dpc-5695	20	20	calcipotriol	calcipotriol	NOUN
dpc-5695	20	21	potentially	potentially	ADV
dpc-5695	20	22	counteracting	counteract	VERB
dpc-5695	20	23	steroid	steroid	NOUN
dpc-5695	20	24	-	-	PUNCT
dpc-5695	20	25	induced	induce	VERB
dpc-5695	20	26	atrophy	atrophy	NOUN
dpc-5695	20	27	.	.	PUNCT
dpc-5695	21	1	the	the	DET
dpc-5695	21	2	foam	foam	NOUN
dpc-5695	21	3	formulation	formulation	NOUN
dpc-5695	21	4	enhances	enhance	VERB
dpc-5695	21	5	patient	patient	ADJ
dpc-5695	21	6	adherence	adherence	NOUN
dpc-5695	21	7	by	by	ADP
dpc-5695	21	8	facilitating	facilitate	VERB
dpc-5695	21	9	ease	ease	NOUN
dpc-5695	21	10	of	of	ADP
dpc-5695	21	11	application	application	NOUN
dpc-5695	21	12	and	and	CCONJ
dpc-5695	21	13	absorption	absorption	NOUN
dpc-5695	21	14	[	[	X
dpc-5695	21	15	2	2	NUM
dpc-5695	21	16	]	]	PUNCT
dpc-5695	21	17	.	.	PUNCT
dpc-5695	22	1	histologically	histologically	PROPN
dpc-5695	22	2	,	,	PUNCT
dpc-5695	22	3	eac	eac	PROPN
dpc-5695	22	4	is	be	AUX
dpc-5695	22	5	defined	define	VERB
dpc-5695	22	6	by	by	ADP
dpc-5695	22	7	a	a	DET
dpc-5695	22	8	superficial	superficial	ADJ
dpc-5695	22	9	perivascular	perivascular	ADJ
dpc-5695	22	10	lymphocytic	lymphocytic	ADJ
dpc-5695	22	11	infiltrate	infiltrate	ADJ
dpc-5695	22	12	,	,	PUNCT
dpc-5695	22	13	variable	variable	ADJ
dpc-5695	22	14	degree	degree	NOUN
dpc-5695	22	15	of	of	ADP
dpc-5695	22	16	spongiosis	spongiosis	NOUN
dpc-5695	22	17	,	,	PUNCT
dpc-5695	22	18	and	and	CCONJ
dpc-5695	22	19	dilated	dilate	VERB
dpc-5695	22	20	dermal	dermal	NOUN
dpc-5695	22	21	vessels	vessel	NOUN
dpc-5695	22	22	.	.	PUNCT
dpc-5695	23	1	lc	lc	PROPN
dpc-5695	23	2	-	-	PUNCT
dpc-5695	23	3	oct	oct	PROPN
dpc-5695	23	4	offers	offer	VERB
dpc-5695	23	5	a	a	DET
dpc-5695	23	6	noninvasive	noninvasive	ADJ
dpc-5695	23	7	method	method	NOUN
dpc-5695	23	8	to	to	PART
dpc-5695	23	9	visualize	visualize	VERB
dpc-5695	23	10	these	these	DET
dpc-5695	23	11	features	feature	NOUN
dpc-5695	23	12	in	in	ADP
dpc-5695	23	13	vivo	vivo	NOUN
dpc-5695	23	14	,	,	PUNCT
dpc-5695	23	15	providing	provide	VERB
dpc-5695	23	16	valuable	valuable	ADJ
dpc-5695	23	17	insights	insight	NOUN
dpc-5695	23	18	into	into	ADP
dpc-5695	23	19	disease	disease	NOUN
dpc-5695	23	20	activity	activity	NOUN
dpc-5695	23	21	and	and	CCONJ
dpc-5695	23	22	treatment	treatment	NOUN
dpc-5695	23	23	outcomes	outcome	NOUN
dpc-5695	23	24	.	.	PUNCT
dpc-5695	24	1	case	case	NOUN
dpc-5695	24	2	presentation	presentation	NOUN
dpc-5695	24	3	five	five	NUM
dpc-5695	24	4	patients	patient	NOUN
dpc-5695	24	5	(	(	PUNCT
dpc-5695	24	6	three	three	NUM
dpc-5695	24	7	females	female	NOUN
dpc-5695	24	8	and	and	CCONJ
dpc-5695	24	9	two	two	NUM
dpc-5695	24	10	males	male	NOUN
dpc-5695	24	11	)	)	PUNCT
dpc-5695	24	12	aged	age	VERB
dpc-5695	24	13	between	between	ADP
dpc-5695	24	14	30	30	NUM
dpc-5695	24	15	and	and	CCONJ
dpc-5695	24	16	55	55	NUM
dpc-5695	24	17	years	year	NOUN
dpc-5695	24	18	were	be	AUX
dpc-5695	24	19	treated	treat	VERB
dpc-5695	24	20	with	with	ADP
dpc-5695	24	21	this	this	DET
dpc-5695	24	22	drug	drug	NOUN
dpc-5695	24	23	combination	combination	NOUN
dpc-5695	24	24	.	.	PUNCT
dpc-5695	25	1	all	all	DET
dpc-5695	25	2	patients	patient	NOUN
dpc-5695	25	3	presented	present	VERB
dpc-5695	25	4	with	with	ADP
dpc-5695	25	5	moderate	moderate	ADJ
dpc-5695	25	6	-	-	PUNCT
dpc-5695	25	7	to	to	ADP
dpc-5695	25	8	-	-	PUNCT
dpc-5695	25	9	severe	severe	ADJ
dpc-5695	25	10	histologically	histologically	PROPN
dpc-5695	25	11	confirmed	confirm	VERB
dpc-5695	25	12	eac	eac	PROPN
dpc-5695	25	13	that	that	PRON
dpc-5695	25	14	had	have	AUX
dpc-5695	25	15	persisted	persist	VERB
dpc-5695	25	16	from	from	ADP
dpc-5695	25	17	six	six	NUM
dpc-5695	25	18	months	month	NOUN
dpc-5695	25	19	to	to	ADP
dpc-5695	25	20	four	four	NUM
dpc-5695	25	21	years	year	NOUN
dpc-5695	25	22	and	and	CCONJ
dpc-5695	25	23	who	who	PRON
dpc-5695	25	24	were	be	AUX
dpc-5695	25	25	refractory	refractory	NOUN
dpc-5695	25	26	to	to	PART
dpc-5695	25	27	prior	prior	VERB
dpc-5695	25	28	corticosteroid	corticosteroid	ADJ
dpc-5695	25	29	treatments	treatment	NOUN
dpc-5695	25	30	.	.	PUNCT
dpc-5695	26	1	in	in	ADP
dpc-5695	26	2	fact	fact	NOUN
dpc-5695	26	3	,	,	PUNCT
dpc-5695	26	4	after	after	ADP
dpc-5695	26	5	initial	initial	ADJ
dpc-5695	26	6	improvement	improvement	NOUN
dpc-5695	26	7	with	with	ADP
dpc-5695	26	8	two	two	NUM
dpc-5695	26	9	months	month	NOUN
dpc-5695	26	10	of	of	ADP
dpc-5695	26	11	topical	topical	ADJ
dpc-5695	26	12	steroid	steroid	NOUN
dpc-5695	26	13	daily	daily	NOUN
dpc-5695	26	14	,	,	PUNCT
dpc-5695	26	15	all	all	DET
dpc-5695	26	16	cases	case	NOUN
dpc-5695	26	17	showed	show	VERB
dpc-5695	26	18	rapid	rapid	ADJ
dpc-5695	26	19	occurrence	occurrence	NOUN
dpc-5695	26	20	after	after	ADP
dpc-5695	26	21	steroid	steroid	PROPN
dpc-5695	26	22	withdrawal	withdrawal	PROPN
dpc-5695	26	23	.	.	PUNCT
dpc-5695	27	1	eac	eac	PROPN
dpc-5695	27	2	was	be	AUX
dpc-5695	27	3	considered	consider	VERB
dpc-5695	27	4	2	2	NUM
dpc-5695	27	5	research	research	NOUN
dpc-5695	27	6	letter	letter	NOUN
dpc-5695	28	1	|	|	ADV
dpc-5695	28	2	dermatol	dermatol	ADJ
dpc-5695	28	3	pract	pract	NOUN
dpc-5695	28	4	concept	concept	NOUN
dpc-5695	28	5	.	.	PUNCT
dpc-5695	29	1	2025;15(4):5695	2025;15(4):5695	NUM
dpc-5695	29	2	idiopathic	idiopathic	ADJ
dpc-5695	29	3	in	in	ADP
dpc-5695	29	4	all	all	DET
dpc-5695	29	5	cases	case	NOUN
dpc-5695	29	6	,	,	PUNCT
dpc-5695	29	7	with	with	ADP
dpc-5695	29	8	no	no	DET
dpc-5695	29	9	clinical	clinical	ADJ
dpc-5695	29	10	and	and	CCONJ
dpc-5695	29	11	biochemistry	biochemistry	NOUN
dpc-5695	29	12	associated	associate	VERB
dpc-5695	29	13	abnormality	abnormality	NOUN
dpc-5695	29	14	.	.	PUNCT
dpc-5695	30	1	the	the	DET
dpc-5695	30	2	treatment	treatment	NOUN
dpc-5695	30	3	protocol	protocol	NOUN
dpc-5695	30	4	consisted	consist	VERB
dpc-5695	30	5	of	of	ADP
dpc-5695	30	6	calcipotriol	calcipotriol	PROPN
dpc-5695	30	7	-	-	PUNCT
dpc-5695	30	8	betamethasone	betamethasone	PROPN
dpc-5695	30	9	foam	foam	NOUN
dpc-5695	30	10	applied	apply	VERB
dpc-5695	30	11	once	once	ADV
dpc-5695	30	12	daily	daily	ADV
dpc-5695	30	13	for	for	ADP
dpc-5695	30	14	two	two	NUM
dpc-5695	30	15	months	month	NOUN
dpc-5695	30	16	,	,	PUNCT
dpc-5695	30	17	followed	follow	VERB
dpc-5695	30	18	by	by	ADP
dpc-5695	30	19	twice	twice	ADJ
dpc-5695	30	20	-	-	PUNCT
dpc-5695	30	21	weekly	weekly	NOUN
dpc-5695	30	22	application	application	NOUN
dpc-5695	30	23	for	for	ADP
dpc-5695	30	24	four	four	NUM
dpc-5695	30	25	additional	additional	ADJ
dpc-5695	30	26	months	month	NOUN
dpc-5695	30	27	.	.	PUNCT
dpc-5695	31	1	patients	patient	NOUN
dpc-5695	31	2	were	be	AUX
dpc-5695	31	3	clinically	clinically	ADV
dpc-5695	31	4	assessed	assess	VERB
dpc-5695	31	5	at	at	ADP
dpc-5695	31	6	eight	eight	NUM
dpc-5695	31	7	weeks	week	NOUN
dpc-5695	31	8	and	and	CCONJ
dpc-5695	31	9	at	at	ADP
dpc-5695	31	10	six	six	NUM
dpc-5695	31	11	months	month	NOUN
dpc-5695	31	12	.	.	PUNCT
dpc-5695	32	1	at	at	ADP
dpc-5695	32	2	eight	eight	NUM
dpc-5695	32	3	weeks	week	NOUN
dpc-5695	32	4	,	,	PUNCT
dpc-5695	32	5	three	three	NUM
dpc-5695	32	6	of	of	ADP
dpc-5695	32	7	the	the	DET
dpc-5695	32	8	five	five	NUM
dpc-5695	32	9	patients	patient	NOUN
dpc-5695	32	10	achieved	achieve	VERB
dpc-5695	32	11	complete	complete	ADJ
dpc-5695	32	12	resolution	resolution	NOUN
dpc-5695	32	13	of	of	ADP
dpc-5695	32	14	lesions	lesion	NOUN
dpc-5695	32	15	(	(	PUNCT
dpc-5695	32	16	figure	figure	NOUN
dpc-5695	32	17	1	1	NUM
dpc-5695	32	18	)	)	PUNCT
dpc-5695	32	19	,	,	PUNCT
dpc-5695	32	20	while	while	SCONJ
dpc-5695	32	21	the	the	DET
dpc-5695	32	22	other	other	ADJ
dpc-5695	32	23	two	two	NUM
dpc-5695	32	24	showed	show	VERB
dpc-5695	32	25	significant	significant	ADJ
dpc-5695	32	26	improvement	improvement	NOUN
dpc-5695	32	27	.	.	PUNCT
dpc-5695	33	1	this	this	DET
dpc-5695	33	2	clinical	clinical	ADJ
dpc-5695	33	3	outcome	outcome	NOUN
dpc-5695	33	4	was	be	AUX
dpc-5695	33	5	maintained	maintain	VERB
dpc-5695	33	6	after	after	ADP
dpc-5695	33	7	six	six	NUM
dpc-5695	33	8	months	month	NOUN
dpc-5695	33	9	.	.	PUNCT
dpc-5695	34	1	at	at	ADP
dpc-5695	34	2	baseline	baseline	NOUN
dpc-5695	34	3	,	,	PUNCT
dpc-5695	34	4	lc	lc	PROPN
dpc-5695	34	5	-	-	PUNCT
dpc-5695	34	6	oct	oct	NOUN
dpc-5695	34	7	imaging	imaging	NOUN
dpc-5695	34	8	of	of	ADP
dpc-5695	34	9	active	active	ADJ
dpc-5695	34	10	lesion	lesion	NOUN
dpc-5695	34	11	borders	border	NOUN
dpc-5695	34	12	showed	show	VERB
dpc-5695	34	13	mild	mild	ADJ
dpc-5695	34	14	epidermal	epidermal	ADJ
dpc-5695	34	15	hyperplasia	hyperplasia	NOUN
dpc-5695	34	16	with	with	ADP
dpc-5695	34	17	spongiosis	spongiosis	NOUN
dpc-5695	34	18	and	and	CCONJ
dpc-5695	34	19	dilated	dilated	ADJ
dpc-5695	34	20	superficial	superficial	ADJ
dpc-5695	34	21	dermal	dermal	NOUN
dpc-5695	34	22	vessels	vessel	NOUN
dpc-5695	34	23	surrounded	surround	VERB
dpc-5695	34	24	by	by	ADP
dpc-5695	34	25	perivascular	perivascular	ADJ
dpc-5695	34	26	infiltrates	infiltrate	NOUN
dpc-5695	34	27	(	(	PUNCT
dpc-5695	34	28	figure	figure	NOUN
dpc-5695	34	29	2a	2a	NUM
dpc-5695	34	30	)	)	PUNCT
dpc-5695	34	31	.	.	PUNCT
dpc-5695	35	1	lc	lc	PROPN
dpc-5695	35	2	-	-	PUNCT
dpc-5695	35	3	oct	oct	PROPN
dpc-5695	35	4	findings	finding	NOUN
dpc-5695	35	5	corroborated	corroborate	VERB
dpc-5695	35	6	the	the	DET
dpc-5695	35	7	clinical	clinical	ADJ
dpc-5695	35	8	outcomes	outcome	NOUN
dpc-5695	35	9	,	,	PUNCT
dpc-5695	35	10	highlighting	highlight	VERB
dpc-5695	35	11	the	the	DET
dpc-5695	35	12	resolution	resolution	NOUN
dpc-5695	35	13	of	of	ADP
dpc-5695	35	14	pathological	pathological	ADJ
dpc-5695	35	15	features	feature	NOUN
dpc-5695	35	16	in	in	ADP
dpc-5695	35	17	successfully	successfully	ADV
dpc-5695	35	18	treated	treat	VERB
dpc-5695	35	19	cases	case	NOUN
dpc-5695	35	20	(	(	PUNCT
dpc-5695	35	21	figure	figure	NOUN
dpc-5695	35	22	2b	2b	NOUN
dpc-5695	35	23	)	)	PUNCT
dpc-5695	35	24	.	.	PUNCT
dpc-5695	36	1	the	the	DET
dpc-5695	36	2	findings	finding	NOUN
dpc-5695	36	3	of	of	ADP
dpc-5695	36	4	this	this	DET
dpc-5695	36	5	case	case	NOUN
dpc-5695	36	6	series	series	NOUN
dpc-5695	36	7	suggest	suggest	VERB
dpc-5695	36	8	that	that	SCONJ
dpc-5695	36	9	calcipotriol	calcipotriol	PROPN
dpc-5695	36	10	-	-	PUNCT
dpc-5695	36	11	betamethasone	betamethasone	PROPN
dpc-5695	36	12	foam	foam	NOUN
dpc-5695	36	13	is	be	AUX
dpc-5695	36	14	a	a	DET
dpc-5695	36	15	safe	safe	ADJ
dpc-5695	36	16	and	and	CCONJ
dpc-5695	36	17	effective	effective	ADJ
dpc-5695	36	18	treatment	treatment	NOUN
dpc-5695	36	19	for	for	ADP
dpc-5695	36	20	eac	eac	PROPN
dpc-5695	36	21	,	,	PUNCT
dpc-5695	36	22	providing	provide	VERB
dpc-5695	36	23	rapid	rapid	ADJ
dpc-5695	36	24	improvement	improvement	NOUN
dpc-5695	36	25	in	in	ADP
dpc-5695	36	26	inflammatory	inflammatory	ADJ
dpc-5695	36	27	and	and	CCONJ
dpc-5695	36	28	epidermal	epidermal	ADJ
dpc-5695	36	29	changes	change	NOUN
dpc-5695	36	30	.	.	PUNCT
dpc-5695	37	1	the	the	DET
dpc-5695	37	2	combination	combination	NOUN
dpc-5695	37	3	targets	target	VERB
dpc-5695	37	4	the	the	DET
dpc-5695	37	5	underlying	underlie	VERB
dpc-5695	37	6	pathogenesis	pathogenesis	NOUN
dpc-5695	37	7	of	of	ADP
dpc-5695	37	8	eac	eac	PROPN
dpc-5695	37	9	while	while	SCONJ
dpc-5695	37	10	reducing	reduce	VERB
dpc-5695	37	11	the	the	DET
dpc-5695	37	12	risks	risk	NOUN
dpc-5695	37	13	associated	associate	VERB
dpc-5695	37	14	with	with	ADP
dpc-5695	37	15	prolonged	prolonged	ADJ
dpc-5695	37	16	corticosteroid	corticosteroid	ADJ
dpc-5695	37	17	use	use	NOUN
dpc-5695	37	18	.	.	PUNCT
dpc-5695	38	1	lc	lc	PROPN
dpc-5695	38	2	-	-	PUNCT
dpc-5695	38	3	oct	oct	PROPN
dpc-5695	38	4	imaging	imaging	NOUN
dpc-5695	38	5	was	be	AUX
dpc-5695	38	6	instrumental	instrumental	ADJ
dpc-5695	38	7	in	in	ADP
dpc-5695	38	8	objectively	objectively	ADV
dpc-5695	38	9	evaluating	evaluate	VERB
dpc-5695	38	10	disease	disease	NOUN
dpc-5695	38	11	activity	activity	NOUN
dpc-5695	38	12	and	and	CCONJ
dpc-5695	38	13	treatment	treatment	NOUN
dpc-5695	38	14	efficacy	efficacy	NOUN
dpc-5695	38	15	.	.	PUNCT
dpc-5695	39	1	baseline	baseline	PROPN
dpc-5695	39	2	imaging	imaging	PROPN
dpc-5695	39	3	revealed	reveal	VERB
dpc-5695	39	4	hallmark	hallmark	ADJ
dpc-5695	39	5	features	feature	NOUN
dpc-5695	39	6	of	of	ADP
dpc-5695	39	7	active	active	ADJ
dpc-5695	39	8	eac	eac	PROPN
dpc-5695	39	9	,	,	PUNCT
dpc-5695	39	10	including	include	VERB
dpc-5695	39	11	spongiosis	spongiosis	NOUN
dpc-5695	39	12	,	,	PUNCT
dpc-5695	39	13	dilated	dilated	ADJ
dpc-5695	39	14	vessels	vessel	NOUN
dpc-5695	39	15	,	,	PUNCT
dpc-5695	39	16	and	and	CCONJ
dpc-5695	39	17	dermal	dermal	ADJ
dpc-5695	39	18	infiltrates	infiltrate	NOUN
dpc-5695	39	19	,	,	PUNCT
dpc-5695	39	20	which	which	PRON
dpc-5695	39	21	progressively	progressively	ADV
dpc-5695	39	22	resolved	resolve	VERB
dpc-5695	39	23	or	or	CCONJ
dpc-5695	39	24	improved	improve	VERB
dpc-5695	39	25	during	during	ADP
dpc-5695	39	26	treatment	treatment	NOUN
dpc-5695	39	27	.	.	PUNCT
dpc-5695	40	1	this	this	DET
dpc-5695	40	2	real	real	ADJ
dpc-5695	40	3	-	-	PUNCT
dpc-5695	40	4	time	time	NOUN
dpc-5695	40	5	monitoring	monitoring	NOUN
dpc-5695	40	6	capability	capability	NOUN
dpc-5695	40	7	provides	provide	VERB
dpc-5695	40	8	clinicians	clinician	NOUN
dpc-5695	40	9	with	with	ADP
dpc-5695	40	10	a	a	DET
dpc-5695	40	11	powerful	powerful	ADJ
dpc-5695	40	12	tool	tool	NOUN
dpc-5695	40	13	to	to	PART
dpc-5695	40	14	guide	guide	VERB
dpc-5695	40	15	therapeutic	therapeutic	ADJ
dpc-5695	40	16	decisions	decision	NOUN
dpc-5695	40	17	and	and	CCONJ
dpc-5695	40	18	track	track	NOUN
dpc-5695	40	19	disease	disease	NOUN
dpc-5695	40	20	progression	progression	NOUN
dpc-5695	40	21	or	or	CCONJ
dpc-5695	40	22	remission	remission	NOUN
dpc-5695	40	23	.	.	PUNCT
dpc-5695	41	1	figure	figure	NOUN
dpc-5695	41	2	1	1	NUM
dpc-5695	41	3	.	.	PUNCT
dpc-5695	42	1	clinical	clinical	ADJ
dpc-5695	42	2	involvement	involvement	NOUN
dpc-5695	42	3	of	of	ADP
dpc-5695	42	4	the	the	DET
dpc-5695	42	5	forearm	forearm	NOUN
dpc-5695	42	6	in	in	ADP
dpc-5695	42	7	a	a	DET
dpc-5695	42	8	48	48	NUM
dpc-5695	42	9	-	-	PUNCT
dpc-5695	42	10	year	year	NOUN
dpc-5695	42	11	-	-	PUNCT
dpc-5695	42	12	old	old	ADJ
dpc-5695	42	13	male	male	NOUN
dpc-5695	42	14	.	.	PUNCT
dpc-5695	43	1	(	(	PUNCT
dpc-5695	43	2	a	a	X
dpc-5695	43	3	)	)	PUNCT
dpc-5695	43	4	annular	annular	ADJ
dpc-5695	43	5	,	,	PUNCT
dpc-5695	43	6	erythematous	erythematous	ADJ
dpc-5695	43	7	,	,	PUNCT
dpc-5695	43	8	and	and	CCONJ
dpc-5695	43	9	scaling	scale	VERB
dpc-5695	43	10	plaques	plaque	NOUN
dpc-5695	43	11	are	be	AUX
dpc-5695	43	12	well	well	ADV
dpc-5695	43	13	observed	observe	VERB
dpc-5695	43	14	.	.	PUNCT
dpc-5695	44	1	(	(	PUNCT
dpc-5695	44	2	b	b	X
dpc-5695	44	3	)	)	PUNCT
dpc-5695	44	4	after	after	ADP
dpc-5695	44	5	six	six	NUM
dpc-5695	44	6	months	month	NOUN
dpc-5695	44	7	,	,	PUNCT
dpc-5695	44	8	complete	complete	ADJ
dpc-5695	44	9	resolution	resolution	NOUN
dpc-5695	44	10	was	be	AUX
dpc-5695	44	11	achieved	achieve	VERB
dpc-5695	44	12	.	.	PUNCT
dpc-5695	45	1	figure	figure	NOUN
dpc-5695	45	2	2	2	NUM
dpc-5695	45	3	.	.	X
dpc-5695	45	4	lc	lc	PROPN
dpc-5695	45	5	-	-	PUNCT
dpc-5695	45	6	oct	oct	NOUN
dpc-5695	45	7	findings	finding	NOUN
dpc-5695	45	8	before	before	ADV
dpc-5695	45	9	and	and	CCONJ
dpc-5695	45	10	after	after	ADP
dpc-5695	45	11	treatment	treatment	NOUN
dpc-5695	45	12	with	with	ADP
dpc-5695	45	13	calcipotriol	calcipotriol	PROPN
dpc-5695	45	14	-	-	PUNCT
dpc-5695	45	15	betamethasone	betamethasone	PROPN
dpc-5695	45	16	foam	foam	NOUN
dpc-5695	45	17	in	in	ADP
dpc-5695	45	18	a	a	DET
dpc-5695	45	19	representative	representative	ADJ
dpc-5695	45	20	patient	patient	NOUN
dpc-5695	45	21	with	with	ADP
dpc-5695	45	22	eac	eac	PROPN
dpc-5695	45	23	.	.	PUNCT
dpc-5695	46	1	lc	lc	PROPN
dpc-5695	46	2	-	-	PUNCT
dpc-5695	46	3	oct	oct	NOUN
dpc-5695	46	4	image	image	NOUN
dpc-5695	46	5	of	of	ADP
dpc-5695	46	6	the	the	DET
dpc-5695	46	7	active	active	ADJ
dpc-5695	46	8	lesion	lesion	NOUN
dpc-5695	46	9	border	border	NOUN
dpc-5695	46	10	before	before	ADP
dpc-5695	46	11	treatment	treatment	NOUN
dpc-5695	46	12	.	.	PUNCT
dpc-5695	47	1	(	(	PUNCT
dpc-5695	47	2	a	a	X
dpc-5695	47	3	)	)	PUNCT
dpc-5695	47	4	evident	evident	ADJ
dpc-5695	47	5	spongiosis	spongiosis	NOUN
dpc-5695	47	6	(	(	PUNCT
dpc-5695	47	7	hyporeflective	hyporeflective	NOUN
dpc-5695	47	8	spaces	space	NOUN
dpc-5695	47	9	within	within	ADP
dpc-5695	47	10	the	the	DET
dpc-5695	47	11	epidermis	epidermis	NOUN
dpc-5695	47	12	,	,	PUNCT
dpc-5695	47	13	yellow	yellow	ADJ
dpc-5695	47	14	star	star	NOUN
dpc-5695	47	15	)	)	PUNCT
dpc-5695	47	16	,	,	PUNCT
dpc-5695	47	17	dilated	dilate	VERB
dpc-5695	47	18	dermal	dermal	NOUN
dpc-5695	47	19	vessels	vessel	NOUN
dpc-5695	47	20	(	(	PUNCT
dpc-5695	47	21	dark	dark	ADJ
dpc-5695	47	22	deep	deep	ADJ
dpc-5695	47	23	spaces	space	NOUN
dpc-5695	47	24	,	,	PUNCT
dpc-5695	47	25	green	green	ADJ
dpc-5695	47	26	triangle	triangle	NOUN
dpc-5695	47	27	)	)	PUNCT
dpc-5695	47	28	,	,	PUNCT
dpc-5695	47	29	and	and	CCONJ
dpc-5695	47	30	perivascular	perivascular	ADJ
dpc-5695	47	31	infiltrate	infiltrate	NOUN
dpc-5695	47	32	are	be	AUX
dpc-5695	47	33	present	present	ADJ
dpc-5695	47	34	.	.	PUNCT
dpc-5695	48	1	the	the	DET
dpc-5695	48	2	epidermis	epidermis	NOUN
dpc-5695	48	3	shows	show	VERB
dpc-5695	48	4	mild	mild	ADJ
dpc-5695	48	5	hyperplasia	hyperplasia	NOUN
dpc-5695	48	6	with	with	ADP
dpc-5695	48	7	architectural	architectural	ADJ
dpc-5695	48	8	disruption	disruption	NOUN
dpc-5695	48	9	.	.	PUNCT
dpc-5695	49	1	(	(	PUNCT
dpc-5695	49	2	b	b	X
dpc-5695	49	3	)	)	PUNCT
dpc-5695	49	4	lc	lc	PROPN
dpc-5695	49	5	-	-	PUNCT
dpc-5695	49	6	oct	oct	NOUN
dpc-5695	49	7	image	image	NOUN
dpc-5695	49	8	of	of	ADP
dpc-5695	49	9	the	the	DET
dpc-5695	49	10	same	same	ADJ
dpc-5695	49	11	lesion	lesion	NOUN
dpc-5695	49	12	after	after	ADP
dpc-5695	49	13	eight	eight	NUM
dpc-5695	49	14	weeks	week	NOUN
dpc-5695	49	15	of	of	ADP
dpc-5695	49	16	daily	daily	ADJ
dpc-5695	49	17	application	application	NOUN
dpc-5695	49	18	of	of	ADP
dpc-5695	49	19	calcipotriol	calcipotriol	PROPN
dpc-5695	49	20	-	-	PUNCT
dpc-5695	49	21	betamethasone	betamethasone	PROPN
dpc-5695	49	22	foam	foam	NOUN
dpc-5695	49	23	.	.	PUNCT
dpc-5695	50	1	normalization	normalization	NOUN
dpc-5695	50	2	of	of	ADP
dpc-5695	50	3	epidermal	epidermal	ADJ
dpc-5695	50	4	structure	structure	NOUN
dpc-5695	50	5	is	be	AUX
dpc-5695	50	6	observed	observe	VERB
dpc-5695	50	7	,	,	PUNCT
dpc-5695	50	8	with	with	ADP
dpc-5695	50	9	resolution	resolution	NOUN
dpc-5695	50	10	of	of	ADP
dpc-5695	50	11	spongiosis	spongiosis	NOUN
dpc-5695	50	12	and	and	CCONJ
dpc-5695	50	13	restoration	restoration	NOUN
dpc-5695	50	14	of	of	ADP
dpc-5695	50	15	dermal	dermal	ADJ
dpc-5695	50	16	architecture	architecture	NOUN
dpc-5695	50	17	with	with	ADP
dpc-5695	50	18	mild	mild	ADJ
dpc-5695	50	19	dilated	dilated	ADJ
dpc-5695	50	20	vessels	vessel	NOUN
dpc-5695	50	21	.	.	PUNCT
dpc-5695	51	1	conclusion	conclusion	NOUN
dpc-5695	51	2	calcipotriol	calcipotriol	PROPN
dpc-5695	51	3	-	-	PUNCT
dpc-5695	51	4	betamethasone	betamethasone	PROPN
dpc-5695	51	5	foam	foam	NOUN
dpc-5695	51	6	,	,	PUNCT
dpc-5695	51	7	combined	combine	VERB
dpc-5695	51	8	with	with	ADP
dpc-5695	51	9	lc	lc	NOUN
dpc-5695	51	10	-	-	PUNCT
dpc-5695	51	11	oct	oct	NOUN
dpc-5695	51	12	monitoring	monitoring	NOUN
dpc-5695	51	13	,	,	PUNCT
dpc-5695	51	14	offers	offer	VERB
dpc-5695	51	15	a	a	DET
dpc-5695	51	16	novel	novel	ADJ
dpc-5695	51	17	approach	approach	NOUN
dpc-5695	51	18	to	to	ADP
dpc-5695	51	19	managing	manage	VERB
dpc-5695	51	20	eac	eac	PROPN
dpc-5695	51	21	.	.	PUNCT
dpc-5695	52	1	the	the	DET
dpc-5695	52	2	small	small	ADJ
dpc-5695	52	3	number	number	NOUN
dpc-5695	52	4	of	of	ADP
dpc-5695	52	5	patients	patient	NOUN
dpc-5695	52	6	,	,	PUNCT
dpc-5695	52	7	open	open	ADJ
dpc-5695	52	8	study	study	NOUN
dpc-5695	52	9	,	,	PUNCT
dpc-5695	52	10	no	no	DET
dpc-5695	52	11	control	control	NOUN
dpc-5695	52	12	group	group	NOUN
dpc-5695	52	13	,	,	PUNCT
dpc-5695	52	14	and	and	CCONJ
dpc-5695	52	15	limited	limited	ADJ
dpc-5695	52	16	follow	follow	NOUN
dpc-5695	52	17	-	-	PUNCT
dpc-5695	52	18	up	up	NOUN
dpc-5695	52	19	are	be	AUX
dpc-5695	52	20	the	the	DET
dpc-5695	52	21	main	main	ADJ
dpc-5695	52	22	limitations	limitation	NOUN
dpc-5695	52	23	of	of	ADP
dpc-5695	52	24	our	our	PRON
dpc-5695	52	25	report	report	NOUN
dpc-5695	52	26	.	.	PUNCT
dpc-5695	53	1	research	research	NOUN
dpc-5695	53	2	letter	letter	NOUN
dpc-5695	53	3	|	|	ADV
dpc-5695	53	4	dermatol	dermatol	ADJ
dpc-5695	53	5	pract	pract	NOUN
dpc-5695	53	6	concept	concept	NOUN
dpc-5695	53	7	.	.	PUNCT
dpc-5695	54	1	2025;15(4):5695	2025;15(4):5695	NUM
dpc-5695	54	2	3	3	NUM
dpc-5695	54	3	thus	thus	ADV
dpc-5695	54	4	,	,	PUNCT
dpc-5695	54	5	larger	large	ADJ
dpc-5695	54	6	studies	study	NOUN
dpc-5695	54	7	are	be	AUX
dpc-5695	54	8	warranted	warrant	VERB
dpc-5695	54	9	to	to	PART
dpc-5695	54	10	confirm	confirm	VERB
dpc-5695	54	11	these	these	DET
dpc-5695	54	12	findings	finding	NOUN
dpc-5695	54	13	and	and	CCONJ
dpc-5695	54	14	further	far	ADV
dpc-5695	54	15	explore	explore	VERB
dpc-5695	54	16	the	the	DET
dpc-5695	54	17	role	role	NOUN
dpc-5695	54	18	of	of	ADP
dpc-5695	54	19	lc	lc	NOUN
dpc-5695	54	20	-	-	PUNCT
dpc-5695	54	21	oct	oct	NOUN
dpc-5695	54	22	in	in	ADP
dpc-5695	54	23	optimizing	optimize	VERB
dpc-5695	54	24	treatment	treatment	NOUN
dpc-5695	54	25	protocols	protocol	NOUN
dpc-5695	54	26	for	for	ADP
dpc-5695	54	27	inflammatory	inflammatory	ADJ
dpc-5695	54	28	skin	skin	NOUN
dpc-5695	54	29	disorders	disorder	NOUN
dpc-5695	54	30	.	.	PUNCT
dpc-5695	55	1	references	reference	NOUN
dpc-5695	55	2	1	1	NUM
dpc-5695	55	3	.	.	PUNCT
dpc-5695	55	4	mcdaniel	mcdaniel	PROPN
dpc-5695	55	5	b.	b.	PROPN
dpc-5695	55	6	,	,	PUNCT
dpc-5695	55	7	cook	cook	VERB
dpc-5695	55	8	c.	c.	PROPN
dpc-5695	55	9	erythema	erythema	ADJ
dpc-5695	55	10	annulare	annulare	PROPN
dpc-5695	55	11	centrifugum	centrifugum	NOUN
dpc-5695	55	12	.	.	PUNCT
dpc-5695	56	1	2024	2024	NUM
dpc-5695	56	2	jun	jun	PROPN
dpc-5695	56	3	8	8	NUM
dpc-5695	56	4	.	.	PUNCT
dpc-5695	57	1	in	in	ADP
dpc-5695	57	2	:	:	PUNCT
dpc-5695	57	3	statpearls	statpearl	NOUN
dpc-5695	58	1	[	[	X
dpc-5695	58	2	internet	internet	NOUN
dpc-5695	58	3	]	]	PUNCT
dpc-5695	58	4	.	.	PUNCT
dpc-5695	59	1	treasure	treasure	NOUN
dpc-5695	59	2	island	island	NOUN
dpc-5695	59	3	(	(	PUNCT
dpc-5695	59	4	fl	fl	PROPN
dpc-5695	59	5	):	):	PUNCT
dpc-5695	59	6	statpearls	statpearl	NOUN
dpc-5695	59	7	publishing	publishing	NOUN
dpc-5695	59	8	;	;	PUNCT
dpc-5695	59	9	2025	2025	NUM
dpc-5695	59	10	.	.	PUNCT
dpc-5695	60	1	2	2	X
dpc-5695	60	2	.	.	X
dpc-5695	60	3	rudnicka	rudnicka	NOUN
dpc-5695	60	4	l	l	PROPN
dpc-5695	60	5	,	,	PUNCT
dpc-5695	60	6	olszewska	olszewska	PROPN
dpc-5695	60	7	m	m	PROPN
dpc-5695	60	8	,	,	PUNCT
dpc-5695	60	9	goldust	goldust	PROPN
dpc-5695	60	10	m	m	PROPN
dpc-5695	60	11	,	,	PUNCT
dpc-5695	60	12	et	et	PROPN
dpc-5695	60	13	al	al	PROPN
dpc-5695	60	14	.	.	PROPN
dpc-5695	60	15	efficacy	efficacy	NOUN
dpc-5695	60	16	and	and	CCONJ
dpc-5695	60	17	safety	safety	NOUN
dpc-5695	60	18	of	of	ADP
dpc-5695	60	19	different	different	ADJ
dpc-5695	60	20	formulations	formulation	NOUN
dpc-5695	60	21	of	of	ADP
dpc-5695	60	22	calcipotriol	calcipotriol	PROPN
dpc-5695	60	23	/	/	SYM
dpc-5695	60	24	betamethasone	betamethasone	PROPN
dpc-5695	60	25	dipropionate	dipropionate	NOUN
dpc-5695	60	26	in	in	ADP
dpc-5695	60	27	psoriasis	psoriasis	NOUN
dpc-5695	60	28	:	:	PUNCT
dpc-5695	60	29	gel	gel	NOUN
dpc-5695	60	30	,	,	PUNCT
dpc-5695	60	31	foam	foam	NOUN
dpc-5695	60	32	,	,	PUNCT
dpc-5695	60	33	and	and	CCONJ
dpc-5695	60	34	ointment	ointment	NOUN
dpc-5695	60	35	.	.	PUNCT
dpc-5695	61	1	j	j	PROPN
dpc-5695	61	2	clin	clin	PROPN
dpc-5695	61	3	med	med	PROPN
dpc-5695	61	4	.	.	PUNCT
dpc-5695	62	1	2021	2021	NUM
dpc-5695	62	2	nov	nov	NOUN
dpc-5695	62	3	28;10(23):5589	28;10(23):5589	NUM
dpc-5695	62	4	.	.	PUNCT
dpc-5695	62	5	  	  	SPACE
dpc-5695	63	1	doi	doi	NOUN
dpc-5695	63	2	:	:	PUNCT
dpc-5695	63	3	10.3390	10.3390	NUM
dpc-5695	63	4	/	/	SYM
dpc-5695	63	5	jcm10235589	jcm10235589	NOUN
dpc-5695	63	6	.	.	PUNCT
dpc-5695	64	1	pmid	pmid	NOUN
dpc-5695	64	2	:	:	PUNCT
dpc-5695	64	3	34884291	34884291	NUM
dpc-5695	64	4	;	;	PUNCT
dpc-5695	64	5	pmcid	pmcid	NOUN
dpc-5695	64	6	:	:	PUNCT
dpc-5695	64	7	pmc8658256	pmc8658256	ADJ
dpc-5695	64	8	.	.	PUNCT